BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16321383)

  • 1. The effect of genetic diversity on angiogenesis.
    Rogers MS; D'Amato RJ
    Exp Cell Res; 2006 Mar; 312(5):561-74. PubMed ID: 16321383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis--a new target for future therapy.
    Pandya NM; Dhalla NS; Santani DD
    Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic loci that control vascular endothelial growth factor-induced angiogenesis.
    Rogers MS; Rohan RM; Birsner AE; D'Amato RJ
    FASEB J; 2003 Nov; 17(14):2112-4. PubMed ID: 12958152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The classical pink-eyed dilution mutation affects angiogenic responsiveness.
    Rogers MS; Boyartchuk V; Rohan RM; Birsner AE; Dietrich WF; D'Amato RJ
    PLoS One; 2012; 7(5):e35237. PubMed ID: 22615734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of the effects of anti-angiogenic compounds on the epiphyseal growth plate.
    Hall AP; Westwood FR; Wadsworth PF
    Toxicol Pathol; 2006; 34(2):131-47. PubMed ID: 16537292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
    Roscoe WA; Welsh ME; Carter DE; Karlik SJ
    J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
    Forooghian F; Das B
    Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGF transcription and mRNA stability are altered by WT1 not DDS(R384W) expression in LNCaP cells.
    Cash J; Korchnak A; Gorman J; Tandon Y; Fraizer G
    Oncol Rep; 2007 Jun; 17(6):1413-9. PubMed ID: 17487399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel three-dimensional analysis tool for vascular trees indicates complete micro-networks, not single capillaries, as the angiogenic endpoint in mice overexpressing human VEGF(165) in the brain.
    Heinzer S; Kuhn G; Krucker T; Meyer E; Ulmann-Schuler A; Stampanoni M; Gassmann M; Marti HH; Müller R; Vogel J
    Neuroimage; 2008 Feb; 39(4):1549-58. PubMed ID: 18077185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [VEGF, anti-vEGF and diseases].
    Corvol P
    Bull Acad Natl Med; 2008 Feb; 192(2):289-300; discussion 300-2. PubMed ID: 18819684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the biology of angiogenesis: review of the most important molecular mechanisms.
    Otrock ZK; Mahfouz RA; Makarem JA; Shamseddine AI
    Blood Cells Mol Dis; 2007; 39(2):212-20. PubMed ID: 17553709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The vasohibin family: a negative regulatory system of angiogenesis genetically programmed in endothelial cells.
    Sato Y; Sonoda H
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):37-41. PubMed ID: 17095714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-angiogenic function of tocotrienol.
    Miyazawa T; Shibata A; Nakagawa K; Tsuzuki T
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():253-6. PubMed ID: 18296349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity.
    Wilkinson-Berka JL; Jones D; Taylor G; Jaworski K; Kelly DJ; Ludbrook SB; Willette RN; Kumar S; Gilbert RE
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1600-5. PubMed ID: 16565398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel role of erythropoietin in proliferative diabetic retinopathy.
    Takagi H; Watanabe D; Suzuma K; Kurimoto M; Suzuma I; Ohashi H; Ojima T; Murakami T
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S62-4. PubMed ID: 17481772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nerve growth factor (NGF) promotes angiogenesis in the quail chorioallantoic membrane.
    Lazarovici P; Gazit A; Staniszewska I; Marcinkiewicz C; Lelkes PI
    Endothelium; 2006; 13(1):51-9. PubMed ID: 16885067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of VEGF and PEDF to choroidal angiogenesis: a need for balanced expressions.
    Tong JP; Yao YF
    Clin Biochem; 2006 Mar; 39(3):267-76. PubMed ID: 16409998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT3: a critical transcription activator in angiogenesis.
    Chen Z; Han ZC
    Med Res Rev; 2008 Mar; 28(2):185-200. PubMed ID: 17457812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene transfer as a tool to induce therapeutic vascular growth in plastic surgery.
    Saaristo A; Suominen E; Yla-Herttuala S
    Handchir Mikrochir Plast Chir; 2005 Dec; 37(6):375-82. PubMed ID: 16388452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.